These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15565744)

  • 41. Epidemiology of hepatitis C virus infection in Pakistan.
    Raja NS; Janjua KA
    J Microbiol Immunol Infect; 2008 Feb; 41(1):4-8. PubMed ID: 18327420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and mode of spread of hepatitis B and C in rural Sindh, Pakistan.
    Abbas Z; Jeswani NL; Kakepoto GN; Islam M; Mehdi K; Jafri W
    Trop Gastroenterol; 2008; 29(4):210-6. PubMed ID: 19323090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic--Nevada, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):513-7. PubMed ID: 18480743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of hepatitis B and C: a Jinnah Postgraduate Medical Centre experience.
    Sami S; Korejo R; Bhutta SZ
    J Obstet Gynaecol Res; 2009 Jun; 35(3):533-8. PubMed ID: 19527395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occupational risk of blood-borne viruses in healthcare workers.
    Van Laer F; Roelandt R; Coenen E
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):712. PubMed ID: 12517010
    [No Abstract]   [Full Text] [Related]  

  • 46. The cost of unsafe injections.
    Miller MA; Pisani E
    Bull World Health Organ; 1999; 77(10):808-11. PubMed ID: 10593028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan.
    Kakepoto GN; Bhally HS; Khaliq G; Kayani N; Burney IA; Siddiqui T; Khurshid M
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):703-6. PubMed ID: 9253870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cost-benefit analysis on the replacement program of ordinary syringes by auto-disposal syringes in China].
    Shi G; Xie YF; Zhang Y; Liu XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):180-3. PubMed ID: 12816706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update. Surveillance of healthcare workers exposed to blood/body fluids and bloodborne pathogens: 1 April, 2000 to 31 March, 2001.
    Nguyen M; Paton S; Villeneuve PJ
    Can Commun Dis Rep; 2001 Dec; 27(24):201-9, 212. PubMed ID: 11775559
    [No Abstract]   [Full Text] [Related]  

  • 50. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia.
    Germain JM; Carbonne A; Thiers V; Gros H; Chastan S; Bouvet E; Astagneau P
    Infect Control Hosp Epidemiol; 2005 Sep; 26(9):789-92. PubMed ID: 16209386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of hepatitis C and B viral markers in patients with chronic liver disease: a study from Northern India.
    Chakravarti A; Verma V
    Indian J Med Microbiol; 2005 Oct; 23(4):273-4. PubMed ID: 16327131
    [No Abstract]   [Full Text] [Related]  

  • 52. Appraisal of the knowledge of Internet users of Pakistan regarding hepatitis using on-line survey.
    Zuberi BF; Zuberi FF; Vasvani A; Faisal N; Afsar S; Rehman J; Qamar B; Jaffery B
    J Ayub Med Coll Abbottabad; 2008; 20(1):91-3. PubMed ID: 19024197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regarding "Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan".
    Luby S; Khan AJ; Altaf A; Hutin Y; Aslam M
    J Clin Gastroenterol; 2002 Aug; 35(2):202; author reply 202-3. PubMed ID: 12172371
    [No Abstract]   [Full Text] [Related]  

  • 54. Regarding "Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan".
    Mujeeb SA
    J Clin Gastroenterol; 2002 Aug; 35(2):201-2; author reply 202-3. PubMed ID: 12172370
    [No Abstract]   [Full Text] [Related]  

  • 55. Safe injections stressed after Nevada outbreak.
    OR Manager; 2008 May; 24(5):25-7. PubMed ID: 18549023
    [No Abstract]   [Full Text] [Related]  

  • 56. Researchers argue that unsafe injections spread HIV more than unsafe sex.
    Crabb C
    Bull World Health Organ; 2003; 81(4):307. PubMed ID: 12764499
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutic response.
    Jafri W; Subhan A
    Trop Gastroenterol; 2008; 29(4):194-201. PubMed ID: 19323087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.
    Ekwueme DU; Weniger BG; Chen RT
    Bull World Health Organ; 2002; 80(11):859-70. PubMed ID: 12481207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case-control study of hepatitis B and hepatitis C in older adults: Do healthcare exposures contribute to burden of new infections?
    Perz JF; Grytdal S; Beck S; Fireteanu AM; Poissant T; Rizzo E; Bornschlegel K; Thomas A; Balter S; Miller J; Klevens RM; Finelli L
    Hepatology; 2013 Mar; 57(3):917-24. PubMed ID: 22383058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C: a study of 100 cases.
    Javed M; Saeed A; Khan IM; Hameed K; Rehman S; Khattak AK; Ahmad I; Khan SA
    J Ayub Med Coll Abbottabad; 2009; 21(3):51-3. PubMed ID: 20929012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.